Related Experiment Videos
Von Hippel-Lindau disease: a genetic study
Journal of Medical Genetics
|July 1, 1991
Summary
Von Hippel-Lindau (VHL) disease is inherited in a dominant pattern with high penetrance in older individuals. This study confirms VHL inheritance patterns and estimates mutation rates, finding no link to parental age.
Area of Science:
- Human Genetics
- Medical Genetics
- Cancer Predisposition Syndromes
Background:
- Von Hippel-Lindau (VHL) disease is a rare genetic disorder associated with an increased risk of various tumors.
- Understanding the genetic transmission and prevalence of VHL disease is crucial for genetic counseling and early diagnosis.
Purpose of the Study:
- To investigate the genetic inheritance patterns of Von Hippel-Lindau disease in familial and isolated cases.
- To confirm the mode of inheritance and penetrance of VHL disease across different age groups.
- To estimate the prevalence, incidence, mutation rate, and reproductive fitness associated with VHL disease.
Main Methods:
- Complex segregation analysis with pointers was applied to 38 kindreds with at least two affected members.
- Prevalence and incidence were calculated based on data from East Anglia.
- Mutation rates were estimated using both direct and indirect methods.
Main Results:
- Dominant inheritance with high penetrance was confirmed, particularly in older age classes (0.96 in 51-60, 0.99 in 61-70 years).
- No evidence of heterogeneity was found between families based on ascertainment methods.
- Point prevalence was 1.89/100,000, with an estimated birth incidence of 2.73/100,000 live births. Reproductive fitness was 0.83. Mutation rates were estimated at 4.4 x 10(-6)/gene/generation (direct) and 2.32 x 10(-6)/gene/generation (indirect).
Conclusions:
- The study confirms dominant inheritance and high penetrance for Von Hippel-Lindau disease.
- The estimated prevalence and incidence provide valuable epidemiological data for VHL disease.
- No association was found between parental age or birth order and the occurrence of new VHL mutations.